Health Care & Life Sciences » Pharmaceuticals | China Medical System Holdings Ltd.

China Medical System Holdings Ltd. | Ownership

Companies that own China Medical System Holdings Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Norges Bank Investment Management
54,964,452
2.21%
7,040,880
0.01%
12/31/2017
The Vanguard Group, Inc.
42,587,678
1.71%
361,000
0%
07/31/2018
JF Asset Management Ltd.
37,590,000
1.51%
0
0.27%
09/28/2017
BlackRock Fund Advisors
33,887,000
1.36%
-48,000
0%
09/06/2018
APG Asset Management NV
22,207,671
0.89%
-2,163,120
0.02%
03/31/2018
Grandeur Peak Global Advisors LLC
22,076,600
0.89%
1,953,000
1.12%
04/30/2018
AllianceBernstein LP
18,880,399
0.76%
1,925,399
0.02%
07/31/2018
Aviva Investors Global Services Ltd.
18,668,166
0.75%
564,000
0.07%
06/30/2018
Dimensional Fund Advisors LP
16,713,600
0.67%
12,000
0.01%
04/30/2018
Nordea Investment Management AB (Denmark)
15,694,465
0.63%
1,902,443
0.04%
07/31/2018

About China Medical System Holdings

View Profile
Address
6/F-8/F, Block B
Shenzhen Guangdong 518052
China
Employees -
Website http://www.cms.net.cn
Updated 07/08/2019
China Medical System Holdings Ltd. engages in the provision of pharmaceutical products and services. The company focuses on the manufacture, marketing, promotion, and sale of drugs. Its products include Plendi, XinHuoSu, Stulln, XiDaKang, YiNuoShu, DanShenTong, Hirudoid, NuoDiKang, Combizym, GanFuLe, Imdur, Parlodel, Lamisil, YinLianQingGan, and MOVICOL.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.